The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment

Stem Cells and Development

Volumn 23, Issue 24, 2014, Pages 2972-2982

  Janel, Alexandre ^a,b   Dubois Galopin, Frédérique ^c   Bourgne, Céline ^a   Berger, Juliette ^a   Tarte, Karin ^d   Boiret Dupré, Nathalie ^a,b   Boisgard, Stéphane ^e   Verrelle, Pierre ^b   Déchelotte, Pierre ^a   Tournilhac, Olivier ^a,b   Berger, Marc G ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CHU PURPAN   (France)

^d INSERM U917   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FIBROBLAST GROWTH FACTOR 2; OXYGEN; BETA GALACTOSIDASE;

ADULT; ARTICLE; BONE MARROW CELL; CELL AGING; CELL CLONE; CELL DISRUPTION; CELL INVASION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; COLONY FORMING UNIT; CONTROLLED STUDY; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STROMA CELL; TUMOR MICROENVIRONMENT; AGED; B LYMPHOCYTE; CELL CULTURE; CYTOLOGY; EXOCYTOSIS; GENETICS; HEMATOPOIESIS; METABOLISM; MIDDLE AGED; MYELOID PROGENITOR CELL; PATHOLOGY; STEM CELL NICHE;

AGED; B-LYMPHOCYTES; BETA-GALACTOSIDASE; CELL AGING; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXOCYTOSIS; FIBROBLASTS; HEMATOPOIESIS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MYELOID PROGENITOR CELLS; STEM CELL NICHE;

EID: 84916896824     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0229     Document Type: Article

References (52)

1. Pangalis GA, PA Roussou, C Kittas, S Kokkinou and P Fessas. (1987). B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit. Cancer 59:767-771
2. Rozman C, E Montserrat, JM Rodríguez-Fernández, R Ayats, T Vallespí, R Parody, A Ríos, D Prados, M Morey and F Gomis. (1984). Bone marrow histologic pattern-The best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 64:642-648
3. Moreton P, B Kennedy, G Lucas, M Leach, SMB Rassam, A Haynes, J Tighe, D Oscier, C Fegan, A Rawstron and P Hillmen. (2005). Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. J Clin Oncol 23:2971-2979
4. Provan D, L Bartlett-Pandite, C Zwicky, D Neuberg, A Maddocks, P Corradini, R Soiffer, J Ritz, LM Nadler and JG Gribben. (1996). Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 88:2228-2235
5. Rawstron AC, B Kennedy, PA Evans, FE Davies, SJ Richards, AP Haynes, NH Russell, G Hale, GJ Morgan, AS Jack and P Hillmen. (2001). Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood 98: 29-35
6. Damle RN, S Temburni, C Calissano, S Yancopoulos, T Banapour, C Sison, SL Allen, KR Rai and N Chiorazzi. (2007). CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood 110:3352-3359
7. Chiorazzi N, KR Rai and M Ferrarini. (2005). Chronic lymphocytic leukemia. N Engl J Med 352:804-815
8. Burger JA, N Tsukada, M Burger, NJ Zvaifler, M DellAquila and TJ Kipps. (2000). Blood-derived nurselike cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96:2655-2663
9. Collins RJ, LA Verschuer, BV Harmon, RL Prentice, JH Pope and JF Kerr. (1989). Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 71:343-350
10. Lagneaux L, A Delforge, C De Bruyn, M Bernier and D Bron. (1999). Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells. Leuk Lymphoma 35:445-453
11. Panayiotidis P, D Jones, K Ganeshaguru, L Foroni and AV Hoffbrand. (1996). Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 92: 97-103
12. Nishio M, T Endo, N Tsukada, J Ohata, S Kitada, JC Reed, NJ Zvaifler and TJ Kipps. (2005). Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106:1012-1020
13. Tsukada N, JA Burger, NJ Zvaifler and TJ Kipps. (2002). Distinctive features of nurselike cells that differentiate in the context of chronic lymphocytic leukemia. Blood 99:1030-1037
14. Ding W, GS Nowakowski, TR Knox, JC Boysen, ML Maas, SM Schwager, W Wu, LE Wellik, AB Dietz, et al. (2009). Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression. Br J Haematol 147:471-483
15. Kay NE, TD Shanafelt, AK Strege, YK Lee, ND Bone and A Raza. (2007). Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an angiogenic switch. Leuk Res 31:899-906
16. Kurtova AV, K Balakrishnan, R Chen, W Ding, S Schnabl, MP Quiroga, M Sivina, WG Wierda, Z Estrov, et al. (2009). Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 114:4441-4450
17. Fecteau J-F, D Messmer, S Zhang, B Cui, L Chen and TJ Kipps. (2013). Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia. Blood 121:971-974
18. Pontikoglou C, M-C Kastrinaki, M Klaus, C Kalpadakis, P Katonis, K Alpantaki, GA Pangalis and HA Papadaki. (2013). Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia. Stem Cells Dev 22:1329-1341
19. Veyrat-Masson R, N Boiret-Dupré, C Rapatel, S Descamps, L Guillouard, J-J Guérin, P Pigeon, S Boisgard, J Chassagne and MG Berger. (2007). Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy. Br J Haematol 139:312-320
20. Boiret N, C Rapatel, S Boisgard, S Charrier, A Tchirkov, C Bresson, L Camilleri, J Berger, L Guillouard, et al. (2003). CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells. Exp Hematol 31: 1275-1283
21. Colter DC, R Class, CM DiGirolamo and DJ Prockop. (2000). Rapid expansion of recycling stem cells in cultures of plastic-Adherent cells from human bone marrow. Proc Natl Acad Sci U S A 97:3213-3218
22. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408
23. Digirolamo CM, D Stokes, D Colter, DG Phinney, R Class and DJ Prockop. (1999). Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281
24. Coppé J-P, CK Patil, F Rodier, Y Sun, DP Munoz, J Goldstein, PS Nelson, P-Y Desprez and J Campisi. (2008). Senescence-Associated secretory phenotypes reveal cellnonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:2853-2868
25. Binsky I, M Haran, D Starlets, Y Gore, F Lantner, N Harpaz, L Leng, DM Goldenberg, L Shvidel, et al. (2007). IL-8 secreted in a macrophage migration-inhibitory factorand CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci U S A 104:13408-13413
26. Burger JA, M Burger and TJ Kipps. (1999). Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 94:3658-3667
27. Blazsek I, XH Liu, A Anjo, P Quittet, M Comisso, B Kim-Triana and JL Misset. (1995). The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones. Exp Hematol 23:309-319
28. Blazsek I, JL Misset, M Comisso and G Mathé. (1988). Hematon: a multicellular functional unit in primary hematopoiesis. Biomed Pharmacother Bioméd 42:661-668
29. Pedersen IM, S Kitada, LM Leoni, JM Zapata, JG Karras, N Tsukada, TJ Kipps, YS Choi, F Bennett and JC Reed. (2002). Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 100:1795-1801
30. Shachar I, S Cohen, A Marom and S Becker-Herman. (2012). Regulation of CLL survival by hypoxia-inducible factor and its target genes. FEBS Lett 586:2906-2910
31. Kay NE, ND Bone, RC Tschumper, KH Howell, SM Geyer, GW Dewald, CA Hanson and DF Jelinek. (2002). B-CLL cells are capable of synthesis and secretion of both pro-And anti-Angiogenic molecules. Leukemia 16:911-919
32. Campisi J and F d Adda di Fagagna. (2007). Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729-740
33. Parrinello S, J-P Coppe, A Krtolica and J Campisi. (2005). Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118:485-496
34. Sethe S, A Scutt and A Stolzing. (2006). Aging of mesenchymal stem cells. Ageing Res Rev 5:91-116
35. Shanafelt TD and NE Kay. (2006). The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol 33:174-185
36. Kawasaki BT and WL Farrar. (2008). Cancer stem cells, CD200 and immunoevasion. Trends Immunol 29:464-468
37. Tai IT and MJ Tang. (2008). SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 11:231-246
38. Montserrat E, N Vinolas, JC Reverter and C Rozman. (1988). Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages. Nouv Rev Fr Hématol 30:359-361
39. Risbud MV, IM Shapiro, A Guttapalli, A Di Martino, KG Danielson, JM Beiner, A Hillibrand, TJ Albert, DG Anderson and AR Vaccaro. (2006). Osteogenic potential of adult human stem cells of the lumbar vertebral body and the iliac crest. Spine 31:83-89
40. Dexter TM, E Spooncer, D Toksoz and LG Lajtha. (1980). The role of cells and their products in the regulation of in vitro stem cell proliferation and granulocyte development. J Supramol Struct 13:513-524
41. Eaves AC, JD Cashman, LA Gaboury and CJ Eaves. (1987). Clinical significance of long-term cultures of myeloid blood cells. Crit Rev Oncol Hematol 7:125-138
42. Gartner S and HS Kaplan. (1980). Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A 77:4756-4759
43. Wang Y-K and CS Chen. (2013). Cell adhesion and mechanical stimulation in the regulation of mesenchymal stem cell differentiation. J Cell Mol Med 17:823-832
44. Baraniak PR and TC McDevitt. (2010). Stem cell paracrine actions and tissue regeneration. Regen Med 5:121-143
45. Ghia P, P Circosta, C Scielzo, A Vallario, A Camporeale, L Granziero and F Caligaris-Cappio. (2005). Differential effects on CLL cell survival exerted by different microenvironmental elements. Curr Top Microbiol Immunol 294: 135-145
46. Ghosh AK, CR Secreto, TR Knox, W Ding, D Mukhopadhyay and NE Kay. (2010). Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 115:1755-1764
47. Plander M, P Ugocsai, S Seegers, E Orsó, A Reichle, G Schmitz, F Hofstädter and G Brockhoff. (2011). Chronic lymphocytic leukemia cells induce anti-Apoptotic effects of bone marrow stroma. Ann Hematol 90:1381-1390
48. Hayden RE, G Pratt, C Roberts, MT Drayson and CM Bunce. (2012). Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leuk Lymphoma 53:537-549
49. Herishanu Y, P Pérez-Galán, D Liu, A Biancotto, S Pittaluga, B Vire, F Gibellini, N Njuguna, E Lee, et al. (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117: 563-574
50. Böttcher S, M Ritgen, K Fischer, S Stilgenbauer, RM Busch, G Fingerle-Rowson, AM Fink, A Bühler, T Zenz, et al. (2012). Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial. J Clin Oncol 30:980-988
51. Dimitriou H, E Linardakis, G Martimianaki, E Stiakaki, CH Perdikogianni, P Charbord and M Kalmanti. (2008). Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases. Cytotherapy 10:125-133
52. Zhao Z-G, Y Liang, K Li, W-M Li, Q-B Li, Z-C Chen and P Zou. (2007). Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases. Stem Cells Dev 16:637-648.